These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18521085)

  • 1. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
    Bessard A; Frémin C; Ezan F; Fautrel A; Gailhouste L; Baffet G
    Oncogene; 2008 Sep; 27(40):5315-25. PubMed ID: 18521085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
    Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
    J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
    Matsumoto K; Okano J; Nagahara T; Murawaki Y
    Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
    Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis.
    Jiang CC; Chen LH; Gillespie S; Wang YF; Kiejda KA; Zhang XD; Hersey P
    Cancer Res; 2007 Oct; 67(20):9750-61. PubMed ID: 17942905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
    Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
    Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTHrP promotes homotypic aggregation of breast cancer cells in three-dimensional cultures.
    Dittmer A; Schunke D; Dittmer J
    Cancer Lett; 2008 Feb; 260(1-2):56-61. PubMed ID: 18035481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway.
    Gu D; Li H; Wang Z; Chen Q; Jiang J; Zhu H
    Laryngoscope; 2007 Oct; 117(10):1782-9. PubMed ID: 17906498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
    J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
    Li J; Johnson SE
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPM6 expression and cell proliferation are up-regulated by phosphorylation of ERK1/2 in renal epithelial cells.
    Ikari A; Okude C; Sawada H; Yamazaki Y; Sugatani J; Miwa M
    Biochem Biophys Res Commun; 2008 May; 369(4):1129-33. PubMed ID: 18339311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells.
    Andrieux LO; Fautrel A; Bessard A; Guillouzo A; Baffet G; Langouët S
    Cancer Res; 2007 Mar; 67(5):2114-23. PubMed ID: 17332341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth.
    Garg M; Kanojia D; Suri S; Suri A
    Cancer; 2009 Dec; 115(24):5688-99. PubMed ID: 19813278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
    Hoeflich KP; O'Brien C; Boyd Z; Cavet G; Guerrero S; Jung K; Januario T; Savage H; Punnoose E; Truong T; Zhou W; Berry L; Murray L; Amler L; Belvin M; Friedman LS; Lackner MR
    Clin Cancer Res; 2009 Jul; 15(14):4649-64. PubMed ID: 19567590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the expression of extracellular signal-regulated kinase 1/2 and the dissociation of pancreatic cancer cells: Involvement of ERK1/2 in the dissociation status of cancer cells.
    Tan X; Egami H; Ishikawa S; Kurizaki T; Tamori Y; Takai E; Hirota M; Ogawa M
    Int J Oncol; 2004 Apr; 24(4):815-20. PubMed ID: 15010817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway.
    Xu HY; Qian AR; Shang P; Xu J; Kong LM; Bian HJ; Chen ZN
    Cancer Lett; 2007 Mar; 247(2):336-44. PubMed ID: 16815629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.